All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

GLP-1 Weight Loss Calculator: Estimate Your Results

Explore GLP-1 weight-loss projections with percentage examples, time horizons, and an explanation of what a calculator estimates.

By FormBlends Editorial Research||
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Key Takeaway

See your GLP-1 options in about 2 minutes. Free and private. See my options →

Free GLP-1 weight loss projection calculator. Enter your starting weight, medication, and timeline to see clinical-trial-based estimates.

Starting a GLP-1 medication? A weight loss projection calculator for GLP-1 shows you what clinical trial data suggests you may experience over the coming months. Enter your starting weight, select your medication, and choose a timeline. The tool generates an estimated weight loss curve based on published research.

Key Takeaways: - Understand what the clinical data shows - Learn how to use the weight loss projection calculator - Factors That Influence Your Results - Setting Realistic Expectations

These projections are averages, not guarantees. Individual results vary based on diet, exercise, genetics, and medication adherence. But having a data-driven estimate helps set realistic expectations and keeps you motivated throughout your treatment.

What GLP-1 trials show about average weight loss

GLP-1 medications have been studied in large clinical trials involving thousands of participants. These trials give us solid data on average weight loss outcomes over time.

Semaglutide 2.4mg weekly was studied in the STEP clinical trial program. Participants who completed 68 weeks of treatment lost an average of about 15 percent of their body weight. For a 250-pound person, that translates to roughly 37 pounds. Results varied widely, with some participants losing more and others less.

Tirzepatide was studied in the SURMOUNT trial program. At the highest dose (15mg weekly), participants lost an average of approximately 21 percent of their body weight over 72 weeks. For a 250-pound person, that could mean around 52 pounds. Tirzepatide showed higher average weight loss than semaglutide in head-to-head comparisons.

Weight loss on GLP-1 medications isn't linear. Most people experience rapid loss in the first 3 to 6 months, followed by a gradual slowdown. Plateaus are normal and expected. The medication continues working even when the scale seems stuck.

It's important to remember that clinical trial participants also received lifestyle counseling. Diet and exercise play a significant role in outcomes. GLP-1 medications work best as part of a thorough approach. Learn about nutrition strategies on GLP-1 to maximize your results.


Free Download: Dose Conversion Table A printable chart showing average weight loss timelines for semaglutide and tirzepatide at each dose level. Includes monthly milestone markers. Get yours free (we'll email it to you instantly.

[Download Now]


How to get your GLP-1 weight loss projection

Our calculator uses published clinical trial averages to model your potential weight loss trajectory. Here is how to get your personalized projection.

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
GLP-1 Weight Loss Calculator: pharmacist in white coat at counter with computer and medication bottles

Enter your starting weight. This is your current weight before beginning treatment. The calculator uses this as your baseline for percentage-based projections.

Select your medication. Choose between semaglutide or tirzepatide. Each medication has different average weight loss outcomes based on clinical data. The calculator applies the appropriate data set.

Choose your timeline. Select 3 months, 6 months, 12 months, or 18 months. The calculator generates a week-by-week projection showing your estimated weight at each point.

Review your projection. The output includes a graph showing your projected weight loss curve, monthly milestone markers, and your estimated final weight at the end of your selected timeline. It also shows the typical range (not just the average) so you understand the spectrum of possible outcomes.

Keep in mind that these projections assume consistent medication use, proper titration, and reasonable lifestyle habits. Skipping doses, stopping medication early, or not addressing nutrition will produce different results.

Track your actual progress against your projection using the FormBlends app. The app logs your weight over time and shows how your real-world results compare to the clinical average.

What affects your GLP-1 weight loss results

Your actual weight loss may differ from the clinical average. Understanding the factors that influence outcomes helps you improve your results.

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →

Starting BMI plays a role. People with higher starting BMIs often lose a larger absolute number of pounds but may lose a similar percentage of body weight. The clinical trials enrolled participants with BMIs of 27 and above.

Medication adherence is critical. Missing doses reduces effectiveness. Taking your injection consistently on the same day each week maintains steady medication levels. Set a weekly reminder and track every dose.

Nutrition quality amplifies results. GLP-1 medications reduce appetite, but the quality of what you eat still matters. Prioritizing protein (aim for 1.0 to 1.2 grams per kilogram of body weight) protects muscle mass and supports metabolism. Read more in our protein planning guide.

Physical activity adds to your calorie deficit and preserves lean mass. Resistance training is especially important on GLP-1 medications to counteract muscle loss during rapid weight loss. Even 2 to 3 strength training sessions per week can make a meaningful difference.

Sleep and stress affect hormones that influence weight. Poor sleep and chronic stress can slow weight loss regardless of medication. Aim for 7 to 9 hours of quality sleep per night.

Genetics and metabolism create individual variation. Some people respond more strongly to GLP-1 medications than others. If your progress seems slower than projected, it doesn't mean the medication isn't working. Discuss your results with your provider at regular check-ins.

Realistic expectations for GLP-1 weight loss

The projection calculator is a planning tool, not a promise. Here is how to use it wisely and stay motivated throughout your plan.

Focus on the trend, not daily weigh-ins. Weight fluctuates daily due to water retention, food volume, and hormonal cycles. Weigh yourself once per week at the same time under the same conditions for the most accurate picture.

Celebrate non-scale victories. Clothing fitting better, improved energy, better sleep, normalized blood sugar, and reduced joint pain are all signs of progress that the scale doesn't capture. Many GLP-1 users report these changes before significant weight loss appears.

Expect plateaus. Nearly everyone hits a plateau at some point. Your body adjusts to its new caloric intake, and weight loss temporarily stalls. Plateaus typically last 2 to 4 weeks. Stay consistent with your medication and lifestyle habits and the scale will usually start moving again.

Adjust your projection as you go. If you switch medications, change doses, or modify your exercise routine, run the calculator again with updated inputs. Your projection should evolve with your treatment plan.

Discuss with your provider. If your actual results are significantly below the projected average after 3 to 4 months, talk to your provider about potential adjustments. This might include comparing semaglutide and tirzepatide to see if a medication switch makes sense.

Projected GLP-1 weight loss over the first 3 months

Clinical data suggests that most people lose 5 to 8 percent of their body weight in the first 3 months of GLP-1 treatment. For a 250-pound person, that's roughly 12 to 20 pounds. Results vary based on dose, medication type, and lifestyle factors.

How firm are these GLP-1 weight loss projections?

No projection or calculator can guarantee results. The estimates are based on clinical trial averages, which represent many individual outcomes. Some people lose more than the average and some lose less. Use the projection as a planning tool, not a guarantee.

Does the GLP-1 projection account for titration?

Yes. The projection models the gradual dose increases that occur during titration. Weight loss is typically slower during the early weeks at lower doses and accelerates as you reach your target dose. The curve reflects this pattern.

What if you lose more weight than projected on GLP-1?

Some people are strong responders to GLP-1 medications and exceed the clinical average. If you're losing weight rapidly, make sure you're eating enough protein and calories to maintain muscle mass and energy. Discuss very rapid weight loss with your provider.

Weight regain after stopping GLP-1 medication in this model

Clinical data indicate that some weight regain can occur after discontinuing GLP-1 medications. The amount varies based on the lifestyle habits you have built during treatment. Continued attention to nutrition, exercise, and behavior modification helps maintain results long-term.

Your health goals is personal) and you deserve a plan that fits. FormBlends connects you with licensed providers who can evaluate your needs and create a personalized protocol.

Start Your Free Assessment →


  1. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. [PubMed | ClinicalTrials.gov | DOI]
  2. Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). Lancet. 2021;397(10278):971-984. [PubMed | ClinicalTrials.gov | DOI]
  3. Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3). JAMA. 2021;325(14):1403-1413. [PubMed | ClinicalTrials.gov | DOI]
  4. Garvey WT, Batterham RL, Bhatt DL, et al. Two-year effects of semaglutide in adults with overweight or obesity (STEP 5). Nat Med. 2022;28(10):2083-2091. [PubMed | ClinicalTrials.gov | DOI]

Sources &. References

  1. Stierman B, Afful J, Carroll MD, et al. National Health and Nutrition Examination Survey 2017-March 2020 Prepandemic Data Files. NCHS Data Brief. No. 492. CDC/NCHS. 2023.
  2. Sumithran P, Prendergast LA, Delbridge E, et al. Long-Term Persistence of Hormonal Adaptations to Weight Loss. N Engl J Med. 2011;365(17):1597-1604. Doi:10.1056/NEJMoa1105816
  3. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Doi:10.1056/NEJMoa2032183
  4. Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2 (Davies et al., Lancet, 2021)). Lancet. 2021;397(10278):971-984. Doi:10.1016/S0140-6736(21)00213-0
  5. Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3 (Wadden et al., JAMA, 2021)). JAMA. 2021;325(14):1403-1413. Doi:10.1001/jama.2021.1831
  6. Garvey WT, Batterham RL, Bhatt DL, et al. Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5 (Garvey et al., Nat Med, 2022)). Nat Med. 2022;28:2083-2091. Doi:10.1038/s41591-022-02026-4
  7. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. Doi:10.1056/NEJMoa2307563

Nothing in this article should be construed as medical advice. The information provided is educational only. Always consult with your healthcare provider before beginning, modifying, or discontinuing any medication or treatment. FormBlends connects patients with licensed providers for individualized care.

Last updated: 2026-03-24

See your options in about 2 minutes

Take the free quiz and see what fits you. Quick, private, and no commitment to continue.

See my options →
GLP-1 Weight Loss Calculator: Estimate Your Results
FormBlends guide cover for GLP-1 Weight Loss Calculator: Estimate Your Results.

Research Snapshot

Research guide
Page type
Research guide
Page metadata
Page updated
2026-10-01
Page metadata
FormBlends official source
Official source
Retatrutide official website
Official source
Semaglutide official website
Official source
Tirzepatide official website
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Page updated: 2026-10-01.

Continue with decision-grade research

Compare the options behind this question

These pages separate verified facts, commercial terms, and unresolved claims so you can check the evidence before choosing a provider.

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Related treatment context

GLP-1 Weight Loss Calculator: Estimate Your Results research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use FormBlends tools and data

Compare provider prices, explore local access and check calculations using FormBlends tools and data.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded semaglutide first month $99, then $190 per month, shipping included.

Next Best Reads

Patient Experience

Semaglutide Cost Over Time: Projection Calculator

Semaglutide Cost Over Time: Projection Calculator: patient experience guidance on semaglutide cost and access, with safety context, decision points,...

GLP-1 Weight Loss

Peptide Reconstitution Calculator (GLP-1)

Free peptide reconstitution calculator (enter your vial size, water volume, and desired dose. Get exact syringe measurements instantly.

GLP-1 Weight Loss

Semaglutide Dose Calculator Guide

Getting your semaglutide dose right is essential for both safety and results.

GLP-1 Weight Loss

Peptide Reconstitution Calculator

Getting your peptide dose right starts with proper reconstitution math. A peptide reconstitution calculator online takes the guesswork out of mixing your medication.

GLP-1 Weight Loss

Water Intake Calculator on GLP-1

Calculate water-intake estimates for GLP-1 users with body-weight examples and a checklist for recording fluids through the day.

GLP-1 Weight Loss

GLP-1 Savings Calculator

Compare monthly and yearly GLP-1 costs using medication, visit, shipping, and coverage inputs, with worked cost and savings examples.

GLP-1 Weight Loss

Semaglutide Dose Titration Calculator

Starting semaglutide means following a step-by-step dose increase schedule. A semaglutide titration calculator helps you map out your entire treatment timeline before you even take your first injection.

GLP-1 Weight Loss

Protein Intake Calculator For GLP-1

Work through protein-intake calculations for GLP-1 users, with body-weight examples and practical ways to count protein in meals.

Patient Experience

Peptide Therapy Cost Calculator 2026

Peptide Therapy Cost Calculator 2026: patient experience guidance on cost and access, with safety context, decision points, and practical next steps.

FormBlends for iPhone

Shot days, doses and progress in one place

The free FormBlends iPhone app tracks GLP-1 doses, shot-day reminders, weight trends, meals and private progress photos.

Free Tools

Calculators to support your weight loss journey.